SINGAPORE SCIENTISTS IDENTIFY MARKERS OF KEY STEM CELL POPULATIONS DRIVING COLORECTAL CANCER FORMATION
Read More
Celebrating Postdocs at A*STAR IMCB’s Inaugural Symposium
New Colon Cancer Models Pinpoint Stem Cells as Cancer Origins
SINGAPORE RESEARCHERS DEVELOP AI TOOL TO PREDICT LIVER CANCER RECURRENCE
Singapore-Developed Cancer Drug Shows Promise as Treatment for Blindness
A*STAR IMCB Scientists Develop Proteomics Pipeline to Strengthen Safety of Alternative Proteins
Phase II Trial Completed – Singapore’s New Anti-Cancer Drug One Step Away from Market
Unlocking Pluripotency: What Powers a Stem Cell’s Identity?
SINGAPORE-DEVELOPED CANCER IMMUNOTHERAPY OFFERS NEW HOPE FOR LATE-STAGE CANCER PATIENTS
A*STAR IMCB Researchers Awarded NRF CRP Funding to Advance Research in Neurodegeneration and Drug Resistance
Local Scientific Research Uncovers Why Melanoma Is Hard to Treat, Plans to Partner with Pharmaceutical Firms to Fight Cancer
A*STAR IMCB CELEBRATES 40 YEARS OF BIOMEDICAL INNOVATION AND IMPACT
Unlocking New Therapeutic Pathways: PRL1 and PRL3 in Tumour Growth and Cancer Immunotherapy
Harnessing Spatial Biology to Uncover Cell-Cell Interactions in Pancreatic Cancer
Nr1h2: A KEY TRANSCRIPTION FACTOR UNLOCKS NEW POTENTIAL IN STEM CELL-BASED EMBRYO MODELS
IMPACT at IMCB: Fostering Postdoctoral Collaboration and Development
Celebrating IMCB's Success at SME Tech Day 2024
SCIENTISTS DISCOVER HOW EXCESSIVE RED MEAT CONSUMPTION INCREASES COLORECTAL CANCER RISK
Celebrating Mentorship Excellence: STAR Mentor Award 2024
Understanding How Enterovirus-A71 Causes Neurodegeneration in Human Motor Neurons







